Patents by Inventor Bing C. Wang

Bing C. Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230416336
    Abstract: The present disclosure provides systems for immune cell regulation and methods of immunotherapy. Systems of the present disclosure for immune cell regulation comprise a chimeric receptor polypeptide, a chimeric adaptor polypeptide, a gene modulating polypeptide (GMP), and a cleavage moiety.
    Type: Application
    Filed: October 28, 2022
    Publication date: December 28, 2023
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Lei S. Qi, Bing C. Wang
  • Patent number: 11111287
    Abstract: The present disclosure provides systems for immune cell regulation and methods of immunotherapy. Systems of the present disclosure for immune cell regulation comprise a chimeric receptor polypeptide, a chimeric adaptor polypeptide, a gene modulating polypeptide (GMP), and a cleavage moiety.
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: September 7, 2021
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Lei S. Qi, Bing C. Wang
  • Publication number: 20190345220
    Abstract: The present disclosure provides systems for immune cell regulation and methods of immunotherapy. Systems of the present disclosure for immune cell regulation comprise a chimeric receptor polypeptide, a chimeric adaptor polypeptide, a gene modulating polypeptide (GMP), and a cleavage moiety.
    Type: Application
    Filed: May 16, 2019
    Publication date: November 14, 2019
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Lei S. Qi, Bing C. Wang
  • Patent number: 10336807
    Abstract: The present disclosure provides systems for immune cell regulation and methods of immunotherapy. Systems of the present disclosure for immune cell regulation comprise a chimeric receptor polypeptide, a chimeric adaptor polypeptide, a gene modulating polypeptide (GMP), and a cleavage moiety.
    Type: Grant
    Filed: July 6, 2018
    Date of Patent: July 2, 2019
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Lei S. Qi, Bing C Wang
  • Publication number: 20180346543
    Abstract: The present disclosure provides systems for immune cell regulation and methods of immunotherapy. Systems of the present disclosure for immune cell regulation comprise a chimeric receptor polypeptide, a chimeric adaptor polypeptide, a gene modulating polypeptide (GMP), and a cleavage moiety.
    Type: Application
    Filed: July 6, 2018
    Publication date: December 6, 2018
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Lei S. Qi, Bing C Wang
  • Patent number: 7035550
    Abstract: A system and method for regenerating optical signals comprising a clock recovery circuit coupled to a transmission line, a first optical gating device having an input port coupled to the transmission line and a clock port coupled to the clock recovery circuit, and a second optical gating device having an input port coupled to a continuous wave (CW) laser and a clock port coupled to the output of the first optical gating device, wherein the optical gating devices may be terahertz optical asymmetric demultiplexers (TOADs).
    Type: Grant
    Filed: December 10, 2003
    Date of Patent: April 25, 2006
    Assignee: The Trustees of Princeton University
    Inventors: Paul R. Prucnal, Bing C. Wang
  • Patent number: 6535662
    Abstract: A Terahertz Optical Asymmetric Demultiplexer (TOAD) having preferably two non-linear elements (NLES) in which the extinction ratio is enhanced by saturating both NLEs when closing a switching window. A data signal input on one port of the TOAD is split onto two optical paths, each including one NLE. The optical paths converge at an output port. To start a switching window, a first control signal is input on an optical path that includes only one of the two NLEs. To close a switching window, one or more control signals are input such that both NLEs receive a control signal at a predetermined time after the first control signal is received by one of the NLEs. Only data signals passing through the first NLE during the switching window are output on the output port. Since both NLEs receive a second control signal at the same time, they decay together and thus avoid creation of unintended switching windows.
    Type: Grant
    Filed: March 9, 2001
    Date of Patent: March 18, 2003
    Assignee: The Trustees of Princeton University
    Inventors: Paul R. Prucnal, Ivan Glesk, Robert Runser, Christine Coldwell, Bing C. Wang
  • Publication number: 20020126946
    Abstract: A Terahertz Optical Asymmetric Demultiplexer (TOAD) having preferably two non-linear elements (NLES) in which the extinction ratio is enhanced by saturating both NLEs when closing a switching window. A data signal input on one port of the TOAD is split onto two optical paths, each including one NLE. The optical paths converge at an output port. To start a switching window, a first control signal is input on an optical path that includes only one of the two NLEs. To close a switching window, one or more control signals are input such that both NLEs receive a control signal at a predetermined time after the first control signal is received by one of the NLEs. Only data signals passing through the first NLE during the switching window are output on the output port. Since both NLEs receive a second control signal at the same time, they decay together and thus avoid creation of unintended switching windows.
    Type: Application
    Filed: March 9, 2001
    Publication date: September 12, 2002
    Inventors: Paul R. Prucnal, Ivan Glesk, Robert Runser, Christine Coldwell, Bing C. Wang